<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC4863900</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC4863900.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">4863900</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">4863900</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">26815786</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1007/s11011-016-9792-3</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">9792</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Subject characteristics</table-caption><table-wrap-foot>Data are means ± SEM or median [interquartile range]Fazekas score for white matter lesions: 0 indicates no lesions; 1 indicates punctate foci; 2 indicates beginning confluence of foci; 3 indicates large confluent areasOGTT oral glucose tolerance test, NEFA non-esterified fatty acids, T2DM type 2 diabetes patients*Statistically significant different from lean (post-hoc Bonferroni corrected P &lt; 0.05)†Statistically significant different from lean and obese (post-hoc Bonferroni corrected P &lt; 0.05)</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Subject characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">Lean (<italic toggle="yes">n</italic> = 15)</th><th colspan="1" rowspan="1">Obese (<italic toggle="yes">n</italic> = 15)</th><th colspan="1" rowspan="1">T2DM (<italic toggle="yes">n</italic> = 16)</th><th colspan="1" rowspan="1">ANOVA <italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age (years)</td><td colspan="1" rowspan="1">57.3 ± 1.9</td><td colspan="1" rowspan="1">57.7 ± 2.2</td><td colspan="1" rowspan="1">61.4 ± 1.5</td><td colspan="1" rowspan="1">0.2</td></tr><tr><td colspan="1" rowspan="1">Gender, male/female (n)</td><td colspan="1" rowspan="1">8/7</td><td colspan="1" rowspan="1">8/7</td><td colspan="1" rowspan="1">8/8</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Weight (kg)</td><td colspan="1" rowspan="1">71.5 ± 2.9</td><td colspan="1" rowspan="1">100.7 ± 3.0*</td><td colspan="1" rowspan="1">97.9 ± 3.0*</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Body mass index (kg/m<sup>2</sup>)</td><td colspan="1" rowspan="1">23.4 ± 0.4</td><td colspan="1" rowspan="1">32.6 ± 0.8*</td><td colspan="1" rowspan="1">34.0 ± 0.9*</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Waist circumference (cm)</td><td colspan="1" rowspan="1">85.7 ± 2.1</td><td colspan="1" rowspan="1">112.3 ± 2.2*</td><td colspan="1" rowspan="1">115.7 ± 1.8*</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Systolic blood pressure (mmHg)</td><td colspan="1" rowspan="1">119 ± 4</td><td colspan="1" rowspan="1">127 ± 3</td><td colspan="1" rowspan="1">141 ± 3†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Diastolic blood pressure (mmHg)</td><td colspan="1" rowspan="1">76 ± 2</td><td colspan="1" rowspan="1">79 ± 2</td><td colspan="1" rowspan="1">83 ± 2</td><td colspan="1" rowspan="1">0.057</td></tr><tr><td colspan="1" rowspan="1">Fasting plasma glucose (mmol/l)</td><td colspan="1" rowspan="1">5.2 ± 0.1</td><td colspan="1" rowspan="1">5.3 ± 0.1</td><td colspan="1" rowspan="1">8.4 ± 0.5†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Glucose 2 h after OGTT (mmol/l)</td><td colspan="1" rowspan="1">5.1 ± 0.3</td><td colspan="1" rowspan="1">5.4 ± 0.2</td><td colspan="1" rowspan="1">–</td><td colspan="1" rowspan="1">0.4</td></tr><tr><td colspan="1" rowspan="1">HbA1c (%)</td><td colspan="1" rowspan="1">5.5 ± 0.03</td><td colspan="1" rowspan="1">5.5 ± 0.06</td><td colspan="1" rowspan="1">6.9 ± 0.22†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">HbA1c (mmol/mol)</td><td colspan="1" rowspan="1">37 ± 0.3</td><td colspan="1" rowspan="1">37 ± 0.7</td><td colspan="1" rowspan="1">52 ± 2.4†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Total cholesterol (mmol/l)</td><td colspan="1" rowspan="1">5.6 ± 0.2</td><td colspan="1" rowspan="1">5.6 ± 0.2</td><td colspan="1" rowspan="1">4.5 ± 0.3†</td><td colspan="1" rowspan="1">0.002</td></tr><tr><td colspan="1" rowspan="1">LDL-cholesterol (mmol/l)</td><td colspan="1" rowspan="1">3.3 ± 0.2</td><td colspan="1" rowspan="1">3.4 ± 0.2</td><td colspan="1" rowspan="1">2.3 ± 0.2†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">HDL-cholesterol (mmol/l)</td><td colspan="1" rowspan="1">1.9 ± 0.1</td><td colspan="1" rowspan="1">1.4 ± 0.1*</td><td colspan="1" rowspan="1">1.3 ± 0.1*</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Triglycerids (mmol/l)</td><td colspan="1" rowspan="1">0.9 ± 0.1</td><td colspan="1" rowspan="1">1.7 ± 0.3</td><td colspan="1" rowspan="1">1.8 ± 0.3</td><td colspan="1" rowspan="1">0.046</td></tr><tr><td colspan="1" rowspan="1">Fasting NEFA (mmol/l)</td><td colspan="1" rowspan="1">0.46 ± 0.04</td><td colspan="1" rowspan="1">0.45 ± 0.03</td><td colspan="1" rowspan="1">0.64 ± 0.04†</td><td colspan="1" rowspan="1">0.001</td></tr><tr><td colspan="1" rowspan="1">Fasting insulin (pmol/l)</td><td colspan="1" rowspan="1">36 ± 2.8</td><td colspan="1" rowspan="1">81 ± 14</td><td colspan="1" rowspan="1">117 ± 17†</td><td colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">Diabetes duration (years)</td><td colspan="1" rowspan="1">–</td><td colspan="1" rowspan="1">–</td><td colspan="1" rowspan="1">7.0 [4.25, 10.75]</td><td colspan="1" rowspan="1">–</td></tr><tr><td colspan="1" rowspan="1">Fazekas score (0; 1; 2; 3)</td><td colspan="1" rowspan="1">6; 7; 2; 0</td><td colspan="1" rowspan="1">8; 5; 2; 0</td><td colspan="1" rowspan="1">5; 9; 2; 0</td><td colspan="1" rowspan="1">0.8</td></tr></tbody></table><table-wrap-foot><p>Data are means ± SEM or median [interquartile range]</p><p>Fazekas score for white matter lesions: 0 indicates no lesions; 1 indicates punctate foci; 2 indicates beginning confluence of foci; 3 indicates large confluent areas</p><p><italic toggle="yes">OGTT</italic> oral glucose tolerance test, <italic toggle="yes">NEFA</italic> non-esterified fatty acids, <italic toggle="yes">T2DM</italic> type 2 diabetes patients</p><p>*Statistically significant different from lean (post-hoc Bonferroni corrected <italic toggle="yes">P</italic> &lt; 0.05)</p><p>†Statistically significant different from lean and obese (post-hoc Bonferroni corrected <italic toggle="yes">P</italic> &lt; 0.05)</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Subject characteristics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>Lean (n = 15)</th><th>Obese (n = 15)</th><th>T2DM (n = 16)</th><th>ANOVA P-value</th></tr></thead><tbody><tr><td>Age (years)</td><td>57.3 ± 1.9</td><td>57.7 ± 2.2</td><td>61.4 ± 1.5</td><td>0.2</td></tr><tr><td>Gender, male/female (n)</td><td>8/7</td><td>8/7</td><td>8/8</td><td>–</td></tr><tr><td>Weight (kg)</td><td>71.5 ± 2.9</td><td>100.7 ± 3.0*</td><td>97.9 ± 3.0*</td><td>&lt;0.001</td></tr><tr><td>Body mass index (kg/m2)</td><td>23.4 ± 0.4</td><td>32.6 ± 0.8*</td><td>34.0 ± 0.9*</td><td>&lt;0.001</td></tr><tr><td>Waist circumference (cm)</td><td>85.7 ± 2.1</td><td>112.3 ± 2.2*</td><td>115.7 ± 1.8*</td><td>&lt;0.001</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>119 ± 4</td><td>127 ± 3</td><td>141 ± 3†</td><td>&lt;0.001</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>76 ± 2</td><td>79 ± 2</td><td>83 ± 2</td><td>0.057</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td>5.2 ± 0.1</td><td>5.3 ± 0.1</td><td>8.4 ± 0.5†</td><td>&lt;0.001</td></tr><tr><td>Glucose 2 h after OGTT (mmol/l)</td><td>5.1 ± 0.3</td><td>5.4 ± 0.2</td><td>–</td><td>0.4</td></tr><tr><td>HbA1c (%)</td><td>5.5 ± 0.03</td><td>5.5 ± 0.06</td><td>6.9 ± 0.22†</td><td>&lt;0.001</td></tr><tr><td>HbA1c (mmol/mol)</td><td>37 ± 0.3</td><td>37 ± 0.7</td><td>52 ± 2.4†</td><td>&lt;0.001</td></tr><tr><td>Total cholesterol (mmol/l)</td><td>5.6 ± 0.2</td><td>5.6 ± 0.2</td><td>4.5 ± 0.3†</td><td>0.002</td></tr><tr><td>LDL-cholesterol (mmol/l)</td><td>3.3 ± 0.2</td><td>3.4 ± 0.2</td><td>2.3 ± 0.2†</td><td>&lt;0.001</td></tr><tr><td>HDL-cholesterol (mmol/l)</td><td>1.9 ± 0.1</td><td>1.4 ± 0.1*</td><td>1.3 ± 0.1*</td><td>&lt;0.001</td></tr><tr><td>Triglycerids (mmol/l)</td><td>0.9 ± 0.1</td><td>1.7 ± 0.3</td><td>1.8 ± 0.3</td><td>0.046</td></tr><tr><td>Fasting NEFA (mmol/l)</td><td>0.46 ± 0.04</td><td>0.45 ± 0.03</td><td>0.64 ± 0.04†</td><td>0.001</td></tr><tr><td>Fasting insulin (pmol/l)</td><td>36 ± 2.8</td><td>81 ± 14</td><td>117 ± 17†</td><td>&lt;0.001</td></tr><tr><td>Diabetes duration (years)</td><td>–</td><td>–</td><td>7.0 [4.25, 10.75]</td><td>–</td></tr><tr><td>Fazekas score (0; 1; 2; 3)</td><td>6; 7; 2; 0</td><td>8; 5; 2; 0</td><td>5; 9; 2; 0</td><td>0.8</td></tr></tbody></table></div>Data are means ± SEM or median [interquartile range]Fazekas score for white matter lesions: 0 indicates no lesions; 1 indicates punctate foci; 2 indicates beginning confluence of foci; 3 indicates large confluent areasOGTT oral glucose tolerance test, NEFA non-esterified fatty acids, T2DM type 2 diabetes patients*Statistically significant different from lean (post-hoc Bonferroni corrected P &lt; 0.05)†Statistically significant different from lean and obese (post-hoc Bonferroni corrected P &lt; 0.05)</transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>Between-group differences in white matter volume and integrity</table-caption><table-wrap-foot>T t-statistic, P-FWEp-value Family-Wise Error corrected for multiple comparisons, R right, L left, MNI Montreal Neurological Institute coordinates in mmNA not applicable</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Between-group differences in white matter volume and integrity</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">Region</th><th colspan="1" rowspan="1">Side</th><th colspan="1" rowspan="1">Cluster (voxels)</th><th colspan="1" rowspan="1">Volume (mL)</th><th colspan="1" rowspan="1">T</th><th colspan="1" rowspan="1">P-<sub>uncorr</sub></th><th colspan="1" rowspan="1">P-<sub>FWE</sub></th><th colspan="1" rowspan="1">MNI coordinates (x, y, z)</th></tr></thead><tbody><tr><td colspan="9" rowspan="1">White matter volume</td></tr><tr><td rowspan="6" colspan="1">T2DM &lt; Lean</td><td rowspan="3" colspan="1">External capsule</td><td rowspan="3" colspan="1">L</td><td rowspan="3" colspan="1">5735</td><td rowspan="3" colspan="1">19.36</td><td colspan="1" rowspan="1">5.64</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">−32,9,2</td></tr><tr><td colspan="1" rowspan="1">4.99</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">−27,8,−13</td></tr><tr><td colspan="1" rowspan="1">4.03</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">17,−16,33</td></tr><tr><td rowspan="3" colspan="1">Inferior Parietal Lobe</td><td rowspan="3" colspan="1">R</td><td rowspan="3" colspan="1">3276</td><td rowspan="3" colspan="1">11.06</td><td colspan="1" rowspan="1">4.69</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">45,−42,54</td></tr><tr><td colspan="1" rowspan="1">4.49</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">47,−31,30</td></tr><tr><td colspan="1" rowspan="1">4.48</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">39,−12,36</td></tr><tr><td colspan="1" rowspan="1">Obese &lt; Lean</td><td colspan="1" rowspan="1">External capsule</td><td colspan="1" rowspan="1">L</td><td colspan="1" rowspan="1">903</td><td colspan="1" rowspan="1">3.05</td><td colspan="1" rowspan="1">4.62</td><td colspan="1" rowspan="1">&lt;0.001</td><td colspan="1" rowspan="1">0.380</td><td colspan="1" rowspan="1">−32,5,−1</td></tr><tr><td colspan="9" rowspan="1">Axial diffusivity</td></tr><tr><td colspan="1" rowspan="1">T2DM &lt; Lean</td><td colspan="1" rowspan="1">Corticospinal tract, inferior fronto-occipital tract, superior longitudinal fasciculus and forceps major</td><td colspan="1" rowspan="1">R</td><td colspan="1" rowspan="1">1803</td><td colspan="1" rowspan="1">1.80</td><td colspan="1" rowspan="1">5.49</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">&lt;0.05</td><td colspan="1" rowspan="1">22,−28,46</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">T</italic> t-statistic, <italic toggle="yes">P-</italic><sub><italic toggle="yes">FWE</italic></sub><italic toggle="yes">p</italic>-value Family-Wise Error corrected for multiple comparisons, <italic toggle="yes">R</italic> right, <italic toggle="yes">L</italic> left, <italic toggle="yes">MNI</italic> Montreal Neurological Institute coordinates in mm</p><p><italic toggle="yes">NA</italic> not applicable</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Between-group differences in white matter volume and integrity</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th>Region</th><th>Side</th><th>Cluster (voxels)</th><th>Volume (mL)</th><th>T</th><th>P-uncorr</th><th>P-FWE</th><th>MNI coordinates (x, y, z)</th></tr></thead><tbody><tr><td colspan="9">White matter volume</td></tr><tr><td rowspan="6">T2DM &lt; Lean</td><td rowspan="3">External capsule</td><td rowspan="3">L</td><td rowspan="3">5735</td><td rowspan="3">19.36</td><td>5.64</td><td>&lt;0.001</td><td>&lt;0.001</td><td>−32,9,2</td></tr><tr><td>4.99</td><td>&lt;0.001</td><td>&lt;0.001</td><td>−27,8,−13</td></tr><tr><td>4.03</td><td>&lt;0.001</td><td>&lt;0.001</td><td>17,−16,33</td></tr><tr><td rowspan="3">Inferior Parietal Lobe</td><td rowspan="3">R</td><td rowspan="3">3276</td><td rowspan="3">11.06</td><td>4.69</td><td>&lt;0.001</td><td>&lt;0.001</td><td>45,−42,54</td></tr><tr><td>4.49</td><td>&lt;0.001</td><td>&lt;0.001</td><td>47,−31,30</td></tr><tr><td>4.48</td><td>&lt;0.001</td><td>&lt;0.001</td><td>39,−12,36</td></tr><tr><td>Obese &lt; Lean</td><td>External capsule</td><td>L</td><td>903</td><td>3.05</td><td>4.62</td><td>&lt;0.001</td><td>0.380</td><td>−32,5,−1</td></tr><tr><td colspan="9">Axial diffusivity</td></tr><tr><td>T2DM &lt; Lean</td><td>Corticospinal tract, inferior fronto-occipital tract, superior longitudinal fasciculus and forceps major</td><td>R</td><td>1803</td><td>1.80</td><td>5.49</td><td>NA</td><td>&lt;0.05</td><td>22,−28,46</td></tr></tbody></table></div>T t-statistic, P-FWEp-value Family-Wise Error corrected for multiple comparisons, R right, L left, MNI Montreal Neurological Institute coordinates in mmNA not applicable</transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Associations between white matter parameters and demographic and clinical characteristics</table-caption><table-wrap-foot>aMean axial diffusivity value for the significant voxels in the comparison between T2DM patients and lean controlsbMean white matter volume of the two significant VBM clusters in the comparison between T2DM patients and lean controls. With these values correlations with biomedical variables were calculated in all subjects (lean, obese and T2DM)</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Associations between white matter parameters and demographic and clinical characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th colspan="2" rowspan="1">Axial diffusivity<sup>a</sup></th><th colspan="2" rowspan="1">White matter volume cluster L<sup>b</sup></th><th colspan="2" rowspan="1">White matter volume cluster R<sup>b</sup></th></tr><tr><th colspan="1" rowspan="1">Spearman’s rho</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th><th colspan="1" rowspan="1">Spearman’s rho</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th><th colspan="1" rowspan="1">Spearman’s rho</th><th colspan="1" rowspan="1"><italic toggle="yes">P</italic>-value</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Age</td><td char="." align="char" colspan="1" rowspan="1">−0.09</td><td char="." align="char" colspan="1" rowspan="1">0.573</td><td char="." align="char" colspan="1" rowspan="1">−0.34</td><td char="." align="char" colspan="1" rowspan="1">0.021</td><td char="." align="char" colspan="1" rowspan="1">−0.30</td><td char="." align="char" colspan="1" rowspan="1">0.041</td></tr><tr><td colspan="1" rowspan="1">Gender</td><td char="." align="char" colspan="1" rowspan="1">0.27</td><td char="." align="char" colspan="1" rowspan="1">0.069</td><td char="." align="char" colspan="1" rowspan="1">0.52</td><td char="." align="char" colspan="1" rowspan="1">&lt;0.001</td><td char="." align="char" colspan="1" rowspan="1">0.54</td><td char="." align="char" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td colspan="1" rowspan="1">BMI</td><td char="." align="char" colspan="1" rowspan="1">−0.47</td><td char="." align="char" colspan="1" rowspan="1">0.001</td><td char="." align="char" colspan="1" rowspan="1">−0.55</td><td char="." align="char" colspan="1" rowspan="1">&lt;0.001</td><td char="." align="char" colspan="1" rowspan="1">−0.43</td><td char="." align="char" colspan="1" rowspan="1">0.003</td></tr><tr><td colspan="1" rowspan="1">Fasting glucose</td><td char="." align="char" colspan="1" rowspan="1">−0.45</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td char="." align="char" colspan="1" rowspan="1">−0.31</td><td char="." align="char" colspan="1" rowspan="1">0.035</td><td char="." align="char" colspan="1" rowspan="1">−0.24</td><td char="." align="char" colspan="1" rowspan="1">0.10</td></tr><tr><td colspan="1" rowspan="1">Fasting insulin</td><td char="." align="char" colspan="1" rowspan="1">−0.44</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td char="." align="char" colspan="1" rowspan="1">−0.40</td><td char="." align="char" colspan="1" rowspan="1">0.006</td><td char="." align="char" colspan="1" rowspan="1">−0.30</td><td char="." align="char" colspan="1" rowspan="1">0.040</td></tr><tr><td colspan="1" rowspan="1">HbA1c</td><td char="." align="char" colspan="1" rowspan="1">−0.38</td><td char="." align="char" colspan="1" rowspan="1">0.008</td><td char="." align="char" colspan="1" rowspan="1">−0.42</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td char="." align="char" colspan="1" rowspan="1">−0.38</td><td char="." align="char" colspan="1" rowspan="1">0.010</td></tr><tr><td colspan="1" rowspan="1">HDL</td><td char="." align="char" colspan="1" rowspan="1">0.27</td><td char="." align="char" colspan="1" rowspan="1">0.07</td><td char="." align="char" colspan="1" rowspan="1">0.17</td><td char="." align="char" colspan="1" rowspan="1">0.3</td><td char="." align="char" colspan="1" rowspan="1">0.15</td><td char="." align="char" colspan="1" rowspan="1">0.35</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Mean axial diffusivity value for the significant voxels in the comparison between T2DM patients and lean controls</p><p><sup>b</sup>Mean white matter volume of the two significant VBM clusters in the comparison between T2DM patients and lean controls. With these values correlations with biomedical variables were calculated in all subjects (lean, obese and T2DM)</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Associations between white matter parameters and demographic and clinical characteristics</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="2">Axial diffusivitya</th><th colspan="2">White matter volume cluster Lb</th><th colspan="2">White matter volume cluster Rb</th></tr><tr><th>Spearman’s rho</th><th>P-value</th><th>Spearman’s rho</th><th>P-value</th><th>Spearman’s rho</th><th>P-value</th></tr></thead><tbody><tr><td>Age</td><td char="." align="char">−0.09</td><td char="." align="char">0.573</td><td char="." align="char">−0.34</td><td char="." align="char">0.021</td><td char="." align="char">−0.30</td><td char="." align="char">0.041</td></tr><tr><td>Gender</td><td char="." align="char">0.27</td><td char="." align="char">0.069</td><td char="." align="char">0.52</td><td char="." align="char">&lt;0.001</td><td char="." align="char">0.54</td><td char="." align="char">&lt;0.001</td></tr><tr><td>BMI</td><td char="." align="char">−0.47</td><td char="." align="char">0.001</td><td char="." align="char">−0.55</td><td char="." align="char">&lt;0.001</td><td char="." align="char">−0.43</td><td char="." align="char">0.003</td></tr><tr><td>Fasting glucose</td><td char="." align="char">−0.45</td><td char="." align="char">0.002</td><td char="." align="char">−0.31</td><td char="." align="char">0.035</td><td char="." align="char">−0.24</td><td char="." align="char">0.10</td></tr><tr><td>Fasting insulin</td><td char="." align="char">−0.44</td><td char="." align="char">0.002</td><td char="." align="char">−0.40</td><td char="." align="char">0.006</td><td char="." align="char">−0.30</td><td char="." align="char">0.040</td></tr><tr><td>HbA1c</td><td char="." align="char">−0.38</td><td char="." align="char">0.008</td><td char="." align="char">−0.42</td><td char="." align="char">0.004</td><td char="." align="char">−0.38</td><td char="." align="char">0.010</td></tr><tr><td>HDL</td><td char="." align="char">0.27</td><td char="." align="char">0.07</td><td char="." align="char">0.17</td><td char="." align="char">0.3</td><td char="." align="char">0.15</td><td char="." align="char">0.35</td></tr></tbody></table></div>aMean axial diffusivity value for the significant voxels in the comparison between T2DM patients and lean controlsbMean white matter volume of the two significant VBM clusters in the comparison between T2DM patients and lean controls. With these values correlations with biomedical variables were calculated in all subjects (lean, obese and T2DM)</transformed-table></extracted-table></extracted-tables-set>